Clinical education library
Our clinical education library offers insights into the diagnosis and treatment of hemophilia and rare bleeding disorders. Watch, listen to and share with your colleagues.
Bleeding Disorder Diagnosis and Treatment for OBGYNs Part 1
19:11
Bleeding Disorder Diagnosis and Treatment for OBGYNs Part 1
In the first of two presentations on rare bleeding disorders in girls and women, Dr Michael Paidas and Dr Ayesha Zia discuss how to recognize important signs and symptoms.
Recognizing Rare Bleeding Disorders
23:18
Recognizing Rare Bleeding Disorders
Dr Miguel Escobar discusses how hematologists and oncologists can diagnose and treat unexplained bleeds in patients with acquired hemophilia.
Bleeding Disorder Diagnosis and Treatment for OBGYNs Part 2
18:09
Bleeding Disorder Diagnosis and Treatment for OBGYNs Part 2
In the 2nd presentation in the series, Dr Joanna Davis and Dr Michael Paidas discuss complications associated with postpartum hemorrhaging and acquired hemophilia.
Addressing clinical care for patients with rare bleeding disorders through the implementation of clinical pathways in the hospital
People with rare bleeding disorders may present to the hospital with bleeding that can be life or limb threatening if they do not receive proper clinical management in a timely manner. Hospital-based clinical pathways are important in providing proper clinical management and achieving optimal patient outcomes. During this presentation, we will review example clinical pathways that were developed, in collaboration with experts in hematology, emergency medicine, and clinical pharmacy, for those patients presenting to the hospital with a rare bleeding disorder. To be successful, a pathway must not only have buy-in and support from leadership, but from the frontline staff who will use the pathway at the point of care. A leader in clinical pathway development will also discuss the key stakeholders involved in the development of a clinical pathway and provide best practices for how to implement a clinical pathway for rare bleeding disorders into your institution.